MCQ: Recent FDA approvals-3 (April 2019) April 5, 2019May 30, 2020 thehematologist.org 12345 20% Question 1 of 5 Loading... 1. Which of the following has been approved for the treatment of newly-diagnosed acute myeloid leukemia in adults 75 years of age or older in 2018? A. Daurismo (glasdegib)B. Tibsovo (ivosidenib)C. Xospata (gilteritinib)D. Rydapt (midostaurin)Question 1 of 5Question 2 of 5 Loading... 2. Which of the following is recombinant modified factor Xa protein that has been developed as a universal antidote to reverse anticoagulant effects of direct or indirect factor Xa inhibitors and approved in May 2018 ? A. Tagraxofusp-erzsB. RavulizumabC. Andexanet alfaD. None of theseQuestion 2 of 5Question 3 of 5 Loading... 3. Which of the following drug has been recently approved (December 21, 2018) for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)? A. CaplacizumabB. RavulizumabC. EculizumabD. None of theseQuestion 3 of 5Question 4 of 5 Loading... 4. Which of the following has been recently approved for the treatment of acquired thrombotic thrombocytopenic purpura in February 2019 ? A. CaplacizumabB. RavulizumabC. EculizumabD. None of theseQuestion 4 of 5Question 5 of 5 Loading... 5. Hematological indication for Keytruda (pembrolizumab) as of now (April 2019) is in ? A. Relapsed/refractory classical Hodgkin lymphomaB. Relapsed/refractory primary mediastinal large B-cell lymphoma C. Approved for both of the indications mentioned aboveD. Approved for none of the indications mentioned aboveQuestion 5 of 5 Loading... Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on WhatsApp (Opens in new window)
Sir recent FDA approval drugs McQ set is quite useful….we need some more exercises like this…thank you Reply
Sir recent FDA approval drugs McQ set is quite useful….we need some more exercises like this…thank you